drugset / Trial / NCT00231153

Study of Omiganan 1% Gel in Preventing Catheter Infections/Colonization in Patients With Central Venous Catheters

NCT00231153

Phase 3 Completed 1859 enrolled Cadence Pharmaceuticals
RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to determine whether treatment with topical omiganan is more effective than treatment with topical povidone-iodine in preventing local catheter site infections and catheter colonization in patients who have central venous catheters.

Timeline

Start
2005-08
Primary completion
2008-06
Completion
2008-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Omiganan Protein / enzyme biologic 1 % Topical
Comparator Povidone-Iodine Other / unclassified 10 % Topical

Indications